AI Insights Center

Market leadership as the largest asset management company in India.

Exceptional revenue and PAT growth (CAGR 51.9% and 207.4% respectively).

Exceptional Revenue CAGR (48.5%) and PAT CAGR (170.5%) over FY24-FY26.

Strong revenue growth (20.2% CAGR) and exceptional PAT growth (55.2% CAGR) over the last two fiscal years.

Exceptional financial growth (Revenue CAGR 26.39%, PAT CAGR 37.2%) and improving margins (EBITDA 25.71%, PAT 16.53%).

Very low overall subscription (0.42x).

Very high and rapidly increasing debt (Debt/Equity 2.24).

Significant regulatory non-compliance issues (delays in filings, EPF/ESIC).

Persistent negative PAT and EBITDA across all reported fiscals (FY24-FY26)

Consistent negative PAT (losses) across all reported fiscal years.

High Pre-IPO P/E of 47.17x and Price-to-Book of 10.01x.

Consistent and significant net losses across all reported periods.

Zero QIB subscription, indicating a complete lack of institutional confidence.

Negative operating cash flows.

Negative operating cash flow in the latest fiscal year (FY26).

High Debt/Equity ratio (2.26).

Persistent and increasing net losses across all reported fiscal years (FY23-FY26).

Lack of detailed business description, competitive analysis, and risk factors in the DRHP.

Inconsistent PAT growth, with a decline in FY26.

Consistently declining PAT and EBITDA margins over recent fiscal years.

Very high post-IPO P/E (92.31x) and Price to Book (6.6x), indicating significant overvaluation.

Past regulatory non-compliance and delayed filings.

Extremely weak subscription across all categories (QIB 0.0x, NII 0.07x, Retail 0.37x).

Very weak GMP (₹0.0) and low overall subscription (1.35x).

Weak market sentiment (zero GMP, undersubscribed retail and HNI portions).

Extreme customer concentration (88-91% revenue from top 5 customers).

High and increasing Debt/Equity ratio (1.19 in FY26).

Extremely weak market sentiment with zero GMP and undersubscribed retail portion (0.87x).

High post-IPO P/E of 60.66x, making the IPO appear expensive compared to most peers.

Inconsistent and negative profit growth from FY24 to FY26.

Extremely poor market sentiment (0 GMP, 0.43x overall subscription, 0.0x QIB subscription).

Critical governance issues: ongoing litigations (criminal, civil, tax) involving the company, promoters, and directors.

Complete absence of information on the objects of the issue, creating uncertainty about capital allocation and future growth strategies.

High valuation (P/E 57.91x) compared to peers and industry average.

Very high and increasing debt-to-equity ratio (4.98x in FY26).

Extremely weak overall subscription (0.23x), with QIB at 0.0x.

Highly inconsistent financial performance (sharp revenue/PAT drop in FY25, negative cash flows in some periods).

Extremely weak market sentiment (0 GMP, very low subscription across all categories).